ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global OTC Anti-Infective Products Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-17Y9294
Home | Market Reports | Health| Pharmacy
Global OTC Anti Infective Products Market Insights and Forecast to 2028
BUY CHAPTERS

Global OTC Anti-Infective Products Market Research Report 2025

Code: QYRE-Auto-17Y9294
Report
March 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
GSK
TEVA
Johnson & Johnson
Novartis
Mylan NV
Sun Pharma
CR SANJIU
Cipla Ltd
Lingrui

OTC Anti-Infective Products Market Size

The global market for OTC Anti-Infective Products was valued at US$ 14230 million in the year 2024 and is projected to reach a revised size of US$ 17930 million by 2031, growing at a CAGR of 3.4% during the forecast period.

OTC Anti-Infective Products Market

OTC Anti-Infective Products Market

Anti-infectives are medicines that work to prevent or treat infections.
Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.
Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Products.
The OTC Anti-Infective Products market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Anti-Infective Products market comprehensively. Regional market sizes, concerning products by Type, by Sales Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Anti-Infective Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channel, and by regions.

Scope of OTC Anti-Infective Products Market Report

Report Metric Details
Report Name OTC Anti-Infective Products Market
Accounted market size in year US$ 14230 million
Forecasted market size in 2031 US$ 17930 million
CAGR 3.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Sales Channel
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, GSK, Teva, Johnson & Johnson, NOVARTIS, MYLAN, Sun Pharma, CR SANJIU, Cipla, Lingrui
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of OTC Anti-Infective Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of OTC Anti-Infective Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is OTC Anti-Infective Products Market growing?

Ans: The OTC Anti-Infective Products Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the OTC Anti-Infective Products Market size in 2031?

Ans: The OTC Anti-Infective Products Market size in 2031 will be US$ 17930 million.

What is the market share of major companies in OTC Anti-Infective Products Market?

Ans: The Top 3 companies hold a share above 10%.

What is the OTC Anti-Infective Products Market share by region?

Ans: Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.

Who are the main players in the OTC Anti-Infective Products Market report?

Ans: The main players in the OTC Anti-Infective Products Market are Bayer, GSK, Teva, Johnson & Johnson, NOVARTIS, MYLAN, Sun Pharma, CR SANJIU, Cipla, Lingrui

What are the Type segmentation covered in the OTC Anti-Infective Products Market report?

Ans: The Types covered in the OTC Anti-Infective Products Market report are Antifungal, Antibacterial, Antiviral, Antiseptics, Others

Recommended Reports

Human Anti-Infectives

Veterinary Anti-Infectives

Infectious Disease Diagnostics

1 OTC Anti-Infective Products Market Overview
1.1 Product Definition
1.2 OTC Anti-Infective Products by Type
1.2.1 Global OTC Anti-Infective Products Market Value Comparison by Type (2024 VS 2031)
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Others
1.3 OTC Anti-Infective Products by Sales Channel
1.3.1 Global OTC Anti-Infective Products Market Value by Sales Channel (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global OTC Anti-Infective Products Market Size Estimates and Forecasts
1.4.1 Global OTC Anti-Infective Products Revenue 2020-2031
1.4.2 Global OTC Anti-Infective Products Sales 2020-2031
1.4.3 Global OTC Anti-Infective Products Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 OTC Anti-Infective Products Market Competition by Manufacturers
2.1 Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2020-2025)
2.2 Global OTC Anti-Infective Products Revenue Market Share by Manufacturers (2020-2025)
2.3 Global OTC Anti-Infective Products Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of OTC Anti-Infective Products, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OTC Anti-Infective Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OTC Anti-Infective Products, Product Type & Application
2.7 Global Key Manufacturers of OTC Anti-Infective Products, Date of Enter into This Industry
2.8 Global OTC Anti-Infective Products Market Competitive Situation and Trends
2.8.1 Global OTC Anti-Infective Products Market Concentration Rate
2.8.2 The Global 5 and 10 Largest OTC Anti-Infective Products Players Market Share by Revenue
2.8.3 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global OTC Anti-Infective Products Market Scenario by Region
3.1 Global OTC Anti-Infective Products Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global OTC Anti-Infective Products Sales by Region: 2020-2031
3.2.1 Global OTC Anti-Infective Products Sales by Region: 2020-2025
3.2.2 Global OTC Anti-Infective Products Sales by Region: 2026-2031
3.3 Global OTC Anti-Infective Products Revenue by Region: 2020-2031
3.3.1 Global OTC Anti-Infective Products Revenue by Region: 2020-2025
3.3.2 Global OTC Anti-Infective Products Revenue by Region: 2026-2031
3.4 North America OTC Anti-Infective Products Market Facts & Figures by Country
3.4.1 North America OTC Anti-Infective Products Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America OTC Anti-Infective Products Sales by Country (2020-2031)
3.4.3 North America OTC Anti-Infective Products Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe OTC Anti-Infective Products Market Facts & Figures by Country
3.5.1 Europe OTC Anti-Infective Products Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe OTC Anti-Infective Products Sales by Country (2020-2031)
3.5.3 Europe OTC Anti-Infective Products Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Region
3.6.1 Asia Pacific OTC Anti-Infective Products Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific OTC Anti-Infective Products Sales by Region (2020-2031)
3.6.3 Asia Pacific OTC Anti-Infective Products Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America OTC Anti-Infective Products Market Facts & Figures by Country
3.7.1 Latin America OTC Anti-Infective Products Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America OTC Anti-Infective Products Sales by Country (2020-2031)
3.7.3 Latin America OTC Anti-Infective Products Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Anti-Infective Products Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa OTC Anti-Infective Products Sales by Country (2020-2031)
3.8.3 Middle East and Africa OTC Anti-Infective Products Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OTC Anti-Infective Products Sales by Type (2020-2031)
4.1.1 Global OTC Anti-Infective Products Sales by Type (2020-2025)
4.1.2 Global OTC Anti-Infective Products Sales by Type (2026-2031)
4.1.3 Global OTC Anti-Infective Products Sales Market Share by Type (2020-2031)
4.2 Global OTC Anti-Infective Products Revenue by Type (2020-2031)
4.2.1 Global OTC Anti-Infective Products Revenue by Type (2020-2025)
4.2.2 Global OTC Anti-Infective Products Revenue by Type (2026-2031)
4.2.3 Global OTC Anti-Infective Products Revenue Market Share by Type (2020-2031)
4.3 Global OTC Anti-Infective Products Price by Type (2020-2031)
5 Segment by Sales Channel
5.1 Global OTC Anti-Infective Products Sales by Sales Channel (2020-2031)
5.1.1 Global OTC Anti-Infective Products Sales by Sales Channel (2020-2025)
5.1.2 Global OTC Anti-Infective Products Sales by Sales Channel (2026-2031)
5.1.3 Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2031)
5.2 Global OTC Anti-Infective Products Revenue by Sales Channel (2020-2031)
5.2.1 Global OTC Anti-Infective Products Revenue by Sales Channel (2020-2025)
5.2.2 Global OTC Anti-Infective Products Revenue by Sales Channel (2026-2031)
5.2.3 Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2020-2031)
5.3 Global OTC Anti-Infective Products Price by Sales Channel (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer OTC Anti-Infective Products Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK OTC Anti-Infective Products Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva OTC Anti-Infective Products Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson OTC Anti-Infective Products Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 NOVARTIS
6.5.1 NOVARTIS Company Information
6.5.2 NOVARTIS Description and Business Overview
6.5.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
6.5.4 NOVARTIS OTC Anti-Infective Products Product Portfolio
6.5.5 NOVARTIS Recent Developments/Updates
6.6 MYLAN
6.6.1 MYLAN Company Information
6.6.2 MYLAN Description and Business Overview
6.6.3 MYLAN OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
6.6.4 MYLAN OTC Anti-Infective Products Product Portfolio
6.6.5 MYLAN Recent Developments/Updates
6.7 Sun Pharma
6.7.1 Sun Pharma Company Information
6.7.2 Sun Pharma Description and Business Overview
6.7.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sun Pharma OTC Anti-Infective Products Product Portfolio
6.7.5 Sun Pharma Recent Developments/Updates
6.8 CR SANJIU
6.8.1 CR SANJIU Company Information
6.8.2 CR SANJIU Description and Business Overview
6.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CR SANJIU OTC Anti-Infective Products Product Portfolio
6.8.5 CR SANJIU Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Company Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cipla OTC Anti-Infective Products Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Lingrui
6.10.1 Lingrui Company Information
6.10.2 Lingrui Description and Business Overview
6.10.3 Lingrui OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Lingrui OTC Anti-Infective Products Product Portfolio
6.10.5 Lingrui Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Anti-Infective Products Industry Chain Analysis
7.2 OTC Anti-Infective Products Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Anti-Infective Products Production Mode & Process Analysis
7.4 OTC Anti-Infective Products Sales and Marketing
7.4.1 OTC Anti-Infective Products Sales Channels
7.4.2 OTC Anti-Infective Products Distributors
7.5 OTC Anti-Infective Products Customer Analysis
8 OTC Anti-Infective Products Market Dynamics
8.1 OTC Anti-Infective Products Industry Trends
8.2 OTC Anti-Infective Products Market Drivers
8.3 OTC Anti-Infective Products Market Challenges
8.4 OTC Anti-Infective Products Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
GSK
TEVA
Johnson & Johnson
Novartis
Mylan NV
Sun Pharma
CR SANJIU
Cipla Ltd
Lingrui
List of Tables
 Table 1. Global OTC Anti-Infective Products Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global OTC Anti-Infective Products Market Value by Sales Channel (2024 VS 2031) & (US$ Million)
 Table 3. Global OTC Anti-Infective Products Market Competitive Situation by Manufacturers in 2024
 Table 4. Global OTC Anti-Infective Products Sales (M Units) of Key Manufacturers (2020-2025)
 Table 5. Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global OTC Anti-Infective Products Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global OTC Anti-Infective Products Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market OTC Anti-Infective Products Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of OTC Anti-Infective Products, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of OTC Anti-Infective Products, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of OTC Anti-Infective Products, Product Type & Application
 Table 12. Global Key Manufacturers of OTC Anti-Infective Products, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global OTC Anti-Infective Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Products as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global OTC Anti-Infective Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global OTC Anti-Infective Products Sales by Region (2020-2025) & (M Units)
 Table 18. Global OTC Anti-Infective Products Sales Market Share by Region (2020-2025)
 Table 19. Global OTC Anti-Infective Products Sales by Region (2026-2031) & (M Units)
 Table 20. Global OTC Anti-Infective Products Sales Market Share by Region (2026-2031)
 Table 21. Global OTC Anti-Infective Products Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global OTC Anti-Infective Products Revenue Market Share by Region (2020-2025)
 Table 23. Global OTC Anti-Infective Products Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global OTC Anti-Infective Products Revenue Market Share by Region (2026-2031)
 Table 25. North America OTC Anti-Infective Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America OTC Anti-Infective Products Sales by Country (2020-2025) & (M Units)
 Table 27. North America OTC Anti-Infective Products Sales by Country (2026-2031) & (M Units)
 Table 28. North America OTC Anti-Infective Products Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America OTC Anti-Infective Products Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe OTC Anti-Infective Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe OTC Anti-Infective Products Sales by Country (2020-2025) & (M Units)
 Table 32. Europe OTC Anti-Infective Products Sales by Country (2026-2031) & (M Units)
 Table 33. Europe OTC Anti-Infective Products Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe OTC Anti-Infective Products Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific OTC Anti-Infective Products Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific OTC Anti-Infective Products Sales by Region (2020-2025) & (M Units)
 Table 37. Asia Pacific OTC Anti-Infective Products Sales by Region (2026-2031) & (M Units)
 Table 38. Asia Pacific OTC Anti-Infective Products Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific OTC Anti-Infective Products Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America OTC Anti-Infective Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America OTC Anti-Infective Products Sales by Country (2020-2025) & (M Units)
 Table 42. Latin America OTC Anti-Infective Products Sales by Country (2026-2031) & (M Units)
 Table 43. Latin America OTC Anti-Infective Products Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America OTC Anti-Infective Products Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa OTC Anti-Infective Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa OTC Anti-Infective Products Sales by Country (2020-2025) & (M Units)
 Table 47. Middle East and Africa OTC Anti-Infective Products Sales by Country (2026-2031) & (M Units)
 Table 48. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global OTC Anti-Infective Products Sales (M Units) by Type (2020-2025)
 Table 51. Global OTC Anti-Infective Products Sales (M Units) by Type (2026-2031)
 Table 52. Global OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
 Table 53. Global OTC Anti-Infective Products Sales Market Share by Type (2026-2031)
 Table 54. Global OTC Anti-Infective Products Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global OTC Anti-Infective Products Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global OTC Anti-Infective Products Revenue Market Share by Type (2020-2025)
 Table 57. Global OTC Anti-Infective Products Revenue Market Share by Type (2026-2031)
 Table 58. Global OTC Anti-Infective Products Price (US$/Unit) by Type (2020-2025)
 Table 59. Global OTC Anti-Infective Products Price (US$/Unit) by Type (2026-2031)
 Table 60. Global OTC Anti-Infective Products Sales (M Units) by Sales Channel (2020-2025)
 Table 61. Global OTC Anti-Infective Products Sales (M Units) by Sales Channel (2026-2031)
 Table 62. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
 Table 63. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2026-2031)
 Table 64. Global OTC Anti-Infective Products Revenue (US$ Million) by Sales Channel (2020-2025)
 Table 65. Global OTC Anti-Infective Products Revenue (US$ Million) by Sales Channel (2026-2031)
 Table 66. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2020-2025)
 Table 67. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2026-2031)
 Table 68. Global OTC Anti-Infective Products Price (US$/Unit) by Sales Channel (2020-2025)
 Table 69. Global OTC Anti-Infective Products Price (US$/Unit) by Sales Channel (2026-2031)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer OTC Anti-Infective Products Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK OTC Anti-Infective Products Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Teva OTC Anti-Infective Products Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson OTC Anti-Infective Products Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. NOVARTIS Company Information
 Table 91. NOVARTIS Description and Business Overview
 Table 92. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. NOVARTIS OTC Anti-Infective Products Product
 Table 94. NOVARTIS Recent Developments/Updates
 Table 95. MYLAN Company Information
 Table 96. MYLAN Description and Business Overview
 Table 97. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. MYLAN OTC Anti-Infective Products Product
 Table 99. MYLAN Recent Developments/Updates
 Table 100. Sun Pharma Company Information
 Table 101. Sun Pharma Description and Business Overview
 Table 102. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sun Pharma OTC Anti-Infective Products Product
 Table 104. Sun Pharma Recent Developments/Updates
 Table 105. CR SANJIU Company Information
 Table 106. CR SANJIU Description and Business Overview
 Table 107. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. CR SANJIU OTC Anti-Infective Products Product
 Table 109. CR SANJIU Recent Developments/Updates
 Table 110. Cipla Company Information
 Table 111. Cipla Description and Business Overview
 Table 112. Cipla OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Cipla OTC Anti-Infective Products Product
 Table 114. Cipla Recent Developments/Updates
 Table 115. Lingrui Company Information
 Table 116. Lingrui Description and Business Overview
 Table 117. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Lingrui OTC Anti-Infective Products Product
 Table 119. Lingrui Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. OTC Anti-Infective Products Distributors List
 Table 123. OTC Anti-Infective Products Customers List
 Table 124. OTC Anti-Infective Products Market Trends
 Table 125. OTC Anti-Infective Products Market Drivers
 Table 126. OTC Anti-Infective Products Market Challenges
 Table 127. OTC Anti-Infective Products Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of OTC Anti-Infective Products
 Figure 2. Global OTC Anti-Infective Products Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global OTC Anti-Infective Products Market Share by Type: 2024 & 2031
 Figure 4. Antifungal Product Picture
 Figure 5. Antibacterial Product Picture
 Figure 6. Antiviral Product Picture
 Figure 7. Antiseptics Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global OTC Anti-Infective Products Market Value by Sales Channel (2020-2031) & (US$ Million)
 Figure 10. Global OTC Anti-Infective Products Market Share by Sales Channel: 2024 & 2031
 Figure 11. Hospital Pharmacies
 Figure 12. Retail Pharmacies
 Figure 13. Online Pharmacies
 Figure 14. Global OTC Anti-Infective Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global OTC Anti-Infective Products Market Size (2020-2031) & (US$ Million)
 Figure 16. Global OTC Anti-Infective Products Sales (2020-2031) & (M Units)
 Figure 17. Global OTC Anti-Infective Products Average Price (US$/Unit) & (2020-2031)
 Figure 18. OTC Anti-Infective Products Report Years Considered
 Figure 19. OTC Anti-Infective Products Sales Share by Manufacturers in 2024
 Figure 20. Global OTC Anti-Infective Products Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest OTC Anti-Infective Products Players: Market Share by Revenue in OTC Anti-Infective Products in 2024
 Figure 22. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global OTC Anti-Infective Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America OTC Anti-Infective Products Sales Market Share by Country (2020-2031)
 Figure 25. North America OTC Anti-Infective Products Revenue Market Share by Country (2020-2031)
 Figure 26. United States OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe OTC Anti-Infective Products Sales Market Share by Country (2020-2031)
 Figure 29. Europe OTC Anti-Infective Products Revenue Market Share by Country (2020-2031)
 Figure 30. Germany OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region (2020-2031)
 Figure 37. China OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America OTC Anti-Infective Products Sales Market Share by Country (2020-2031)
 Figure 47. Latin America OTC Anti-Infective Products Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE OTC Anti-Infective Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of OTC Anti-Infective Products by Type (2020-2031)
 Figure 57. Global Revenue Market Share of OTC Anti-Infective Products by Type (2020-2031)
 Figure 58. Global OTC Anti-Infective Products Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of OTC Anti-Infective Products by Sales Channel (2020-2031)
 Figure 60. Global Revenue Market Share of OTC Anti-Infective Products by Sales Channel (2020-2031)
 Figure 61. Global OTC Anti-Infective Products Price (US$/Unit) by Sales Channel (2020-2031)
 Figure 62. OTC Anti-Infective Products Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global OTC Anti Infective Medicine Market Research Report 2025
OTC Anti Infective Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti infectives Medicine Market Research Report 2025
Anti Infective Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Anti Infective Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Anti Infective Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Infective Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Anti infectives Market Insights Forecast to 2030
Global Pets Anti infectives Market Insights Forecast to 2030
Global Anti Infective Medications Market Research Report 2024
Global Animal Anti Infective Medicine Market Insights Forecast to 2030
Global Pets Anti Infective Medicine Market Insights Forecast to 2030
Global Ophthalmic Anti infective Drug Market Research Report 2025
Systemic Anti Infectives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Anti Infective Drugs Market Research Report 2025
Global Anti Infective Ophthalmic Market Insights Forecast to 2030
Global Animal Anti Infective Agents Market Research Report 2024
Global Anti infective Ophthalmic Preparation Market Research Report 2024
Global Livestock Anti Infective Medicine Market Insights Forecast to 2030
Global Livestock Anti infectives Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions